3.25.2 html 210 268 1 false 65 0 false 9 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.madrigalpharma.com/role/CoverPage Cover Page Cover 1 false false R2.htm 9952151 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 9952152 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 9952153 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 9952154 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Sheet http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Statements 5 false false R6.htm 9952155 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY Sheet http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY Statements 6 false false R7.htm 9952156 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 9952157 - Disclosure - Organization, Business, and Basis of Presentation Sheet http://www.madrigalpharma.com/role/OrganizationBusinessandBasisofPresentation Organization, Business, and Basis of Presentation Notes 8 false false R9.htm 9952158 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.madrigalpharma.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 9952159 - Disclosure - Liquidity and Uncertainties Sheet http://www.madrigalpharma.com/role/LiquidityandUncertainties Liquidity and Uncertainties Notes 10 false false R11.htm 9952160 - Disclosure - Product Revenue, Net Sheet http://www.madrigalpharma.com/role/ProductRevenueNet Product Revenue, Net Notes 11 false false R12.htm 9952161 - Disclosure - Cash, Cash Equivalents, Restricted Cash and Marketable Securities Sheet http://www.madrigalpharma.com/role/CashCashEquivalentsRestrictedCashandMarketableSecurities Cash, Cash Equivalents, Restricted Cash and Marketable Securities Notes 12 false false R13.htm 9952162 - Disclosure - Inventory Sheet http://www.madrigalpharma.com/role/Inventory Inventory Notes 13 false false R14.htm 9952163 - Disclosure - Accrued Liabilities Sheet http://www.madrigalpharma.com/role/AccruedLiabilities Accrued Liabilities Notes 14 false false R15.htm 9952164 - Disclosure - Long Term Debt Sheet http://www.madrigalpharma.com/role/LongTermDebt Long Term Debt Notes 15 false false R16.htm 9952165 - Disclosure - Stockholders' Equity Sheet http://www.madrigalpharma.com/role/StockholdersEquity Stockholders' Equity Notes 16 false false R17.htm 9952166 - Disclosure - Stock-based Compensation Sheet http://www.madrigalpharma.com/role/StockbasedCompensation Stock-based Compensation Notes 17 false false R18.htm 9952167 - Disclosure - Commitments and Contingencies Sheet http://www.madrigalpharma.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 18 false false R19.htm 9952168 - Disclosure - Segment Information Sheet http://www.madrigalpharma.com/role/SegmentInformation Segment Information Notes 19 false false R20.htm 9952169 - Disclosure - Subsequent Events Sheet http://www.madrigalpharma.com/role/SubsequentEvents Subsequent Events Notes 20 false false R21.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 21 false false R22.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 22 false false R23.htm 9955511 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.madrigalpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.madrigalpharma.com/role/SummaryofSignificantAccountingPolicies 23 false false R24.htm 9955512 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.madrigalpharma.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.madrigalpharma.com/role/SummaryofSignificantAccountingPolicies 24 false false R25.htm 9955513 - Disclosure - Product Revenue, Net (Tables) Sheet http://www.madrigalpharma.com/role/ProductRevenueNetTables Product Revenue, Net (Tables) Tables http://www.madrigalpharma.com/role/ProductRevenueNet 25 false false R26.htm 9955514 - Disclosure - Cash, Cash Equivalents, Restricted Cash and Marketable Securities (Tables) Sheet http://www.madrigalpharma.com/role/CashCashEquivalentsRestrictedCashandMarketableSecuritiesTables Cash, Cash Equivalents, Restricted Cash and Marketable Securities (Tables) Tables http://www.madrigalpharma.com/role/CashCashEquivalentsRestrictedCashandMarketableSecurities 26 false false R27.htm 9955515 - Disclosure - Inventory (Tables) Sheet http://www.madrigalpharma.com/role/InventoryTables Inventory (Tables) Tables http://www.madrigalpharma.com/role/Inventory 27 false false R28.htm 9955516 - Disclosure - Accrued Liabilities (Tables) Sheet http://www.madrigalpharma.com/role/AccruedLiabilitiesTables Accrued Liabilities (Tables) Tables http://www.madrigalpharma.com/role/AccruedLiabilities 28 false false R29.htm 9955517 - Disclosure - Long Term Debt (Tables) Sheet http://www.madrigalpharma.com/role/LongTermDebtTables Long Term Debt (Tables) Tables http://www.madrigalpharma.com/role/LongTermDebt 29 false false R30.htm 9955518 - Disclosure - Stock-based Compensation (Tables) Sheet http://www.madrigalpharma.com/role/StockbasedCompensationTables Stock-based Compensation (Tables) Tables http://www.madrigalpharma.com/role/StockbasedCompensation 30 false false R31.htm 9955519 - Disclosure - Segment Information (Tables) Sheet http://www.madrigalpharma.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.madrigalpharma.com/role/SegmentInformation 31 false false R32.htm 9955520 - Disclosure - Summary of Significant Accounting Policies - Income Taxes (Details) Sheet http://www.madrigalpharma.com/role/SummaryofSignificantAccountingPoliciesIncomeTaxesDetails Summary of Significant Accounting Policies - Income Taxes (Details) Details 32 false false R33.htm 9955521 - Disclosure - Summary of Significant Accounting Policies - Schedule of Basic and Diluted Loss Per Common Share (Details) Sheet http://www.madrigalpharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedLossPerCommonShareDetails Summary of Significant Accounting Policies - Schedule of Basic and Diluted Loss Per Common Share (Details) Details 33 false false R34.htm 9955522 - Disclosure - Liquidity and Uncertainties (Details) Sheet http://www.madrigalpharma.com/role/LiquidityandUncertaintiesDetails Liquidity and Uncertainties (Details) Details http://www.madrigalpharma.com/role/LiquidityandUncertainties 34 false false R35.htm 9955523 - Disclosure - Product Revenue, Net - Schedule Of Gross To Net Adjustments Reserve (Details) Sheet http://www.madrigalpharma.com/role/ProductRevenueNetScheduleOfGrossToNetAdjustmentsReserveDetails Product Revenue, Net - Schedule Of Gross To Net Adjustments Reserve (Details) Details 35 false false R36.htm 9955524 - Disclosure - Product Revenue, Net - Schedule of Concentrations of Credit Risk and Significant Customers (Details) Sheet http://www.madrigalpharma.com/role/ProductRevenueNetScheduleofConcentrationsofCreditRiskandSignificantCustomersDetails Product Revenue, Net - Schedule of Concentrations of Credit Risk and Significant Customers (Details) Details 36 false false R37.htm 9955525 - Disclosure - Cash, Cash Equivalents, Restricted Cash and Marketable Securities - Narrative (Details) Sheet http://www.madrigalpharma.com/role/CashCashEquivalentsRestrictedCashandMarketableSecuritiesNarrativeDetails Cash, Cash Equivalents, Restricted Cash and Marketable Securities - Narrative (Details) Details http://www.madrigalpharma.com/role/CashCashEquivalentsRestrictedCashandMarketableSecuritiesTables 37 false false R38.htm 9955526 - Disclosure - Cash, Cash Equivalents, Restricted Cash and Marketable Securities - Schedule of Cash, Cash Equivalents and Available-for-Sale Marketable Securities (Details) Sheet http://www.madrigalpharma.com/role/CashCashEquivalentsRestrictedCashandMarketableSecuritiesScheduleofCashCashEquivalentsandAvailableforSaleMarketableSecuritiesDetails Cash, Cash Equivalents, Restricted Cash and Marketable Securities - Schedule of Cash, Cash Equivalents and Available-for-Sale Marketable Securities (Details) Details 38 false false R39.htm 9955527 - Disclosure - Inventory (Details) Sheet http://www.madrigalpharma.com/role/InventoryDetails Inventory (Details) Details http://www.madrigalpharma.com/role/InventoryTables 39 false false R40.htm 9955528 - Disclosure - Accrued Liabilities (Details) Sheet http://www.madrigalpharma.com/role/AccruedLiabilitiesDetails Accrued Liabilities (Details) Details http://www.madrigalpharma.com/role/AccruedLiabilitiesTables 40 false false R41.htm 9955529 - Disclosure - Long Term Debt - Narrative (Details) Sheet http://www.madrigalpharma.com/role/LongTermDebtNarrativeDetails Long Term Debt - Narrative (Details) Details 41 false false R42.htm 9955530 - Disclosure - Long Term Debt - Schedule of Maturities of Long-Term Debt (Details) Sheet http://www.madrigalpharma.com/role/LongTermDebtScheduleofMaturitiesofLongTermDebtDetails Long Term Debt - Schedule of Maturities of Long-Term Debt (Details) Details 42 false false R43.htm 9955531 - Disclosure - Stockholders' Equity- Common Stock (Details) Sheet http://www.madrigalpharma.com/role/StockholdersEquityCommonStockDetails Stockholders' Equity- Common Stock (Details) Details 43 false false R44.htm 9955532 - Disclosure - Stockholders' Equity - Preferred Stock (Details) Sheet http://www.madrigalpharma.com/role/StockholdersEquityPreferredStockDetails Stockholders' Equity - Preferred Stock (Details) Details 44 false false R45.htm 9955533 - Disclosure - Stockholders' Equity - 2024 Public Offering (Details) Sheet http://www.madrigalpharma.com/role/StockholdersEquity2024PublicOfferingDetails Stockholders' Equity - 2024 Public Offering (Details) Details 45 false false R46.htm 9955534 - Disclosure - Stockholders' Equity - At The Market Issuance Sales Agreement (Details) Sheet http://www.madrigalpharma.com/role/StockholdersEquityAtTheMarketIssuanceSalesAgreementDetails Stockholders' Equity - At The Market Issuance Sales Agreement (Details) Details 46 false false R47.htm 9955535 - Disclosure - Stock-based Compensation - Narrative (Details) Sheet http://www.madrigalpharma.com/role/StockbasedCompensationNarrativeDetails Stock-based Compensation - Narrative (Details) Details 47 false false R48.htm 9955536 - Disclosure - Stock-based Compensation - Schedule of Stock Option (Details) Sheet http://www.madrigalpharma.com/role/StockbasedCompensationScheduleofStockOptionDetails Stock-based Compensation - Schedule of Stock Option (Details) Details 48 false false R49.htm 9955537 - Disclosure - Stock-based Compensation - Schedule of Restricted Stock Units (Details) Sheet http://www.madrigalpharma.com/role/StockbasedCompensationScheduleofRestrictedStockUnitsDetails Stock-based Compensation - Schedule of Restricted Stock Units (Details) Details 49 false false R50.htm 9955538 - Disclosure - Stock-based Compensation - Schedule of Performance-Based Restricted Stock Units (Details) Sheet http://www.madrigalpharma.com/role/StockbasedCompensationScheduleofPerformanceBasedRestrictedStockUnitsDetails Stock-based Compensation - Schedule of Performance-Based Restricted Stock Units (Details) Details 50 false false R51.htm 9955539 - Disclosure - Stock-based Compensation - Schedule of Stock-Based Compensation Expense (Details) Sheet http://www.madrigalpharma.com/role/StockbasedCompensationScheduleofStockBasedCompensationExpenseDetails Stock-based Compensation - Schedule of Stock-Based Compensation Expense (Details) Details 51 false false R52.htm 9955540 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.madrigalpharma.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.madrigalpharma.com/role/CommitmentsandContingencies 52 false false R53.htm 9955541 - Disclosure - Segment Information - Narrative (Details) Sheet http://www.madrigalpharma.com/role/SegmentInformationNarrativeDetails Segment Information - Narrative (Details) Details 53 false false R54.htm 9955542 - Disclosure - Segment Information - Schedule of Segment Information (Details) Sheet http://www.madrigalpharma.com/role/SegmentInformationScheduleofSegmentInformationDetails Segment Information - Schedule of Segment Information (Details) Details 54 false false R55.htm 9955543 - Disclosure - Subsequent Events (Details) Sheet http://www.madrigalpharma.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.madrigalpharma.com/role/SubsequentEvents 55 false false All Reports Book All Reports mdgl-20250630.htm mdgl-20250630.xsd mdgl-20250630_cal.xml mdgl-20250630_def.xml mdgl-20250630_lab.xml mdgl-20250630_pre.xml http://fasb.org/srt/2025 http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 true true